Injective INJ
Current Price
$3.66 -8.12%
$0.6100 Daily Range (16.67%)
$3.38$3.99
$85.75M Daily Volume
1,089 BTC
Vol/MktCap: 23.42%
Market Performance
0.10% Relative BTC Volume
The total volume of Injective is $85.75M over the past 24 hours, compared to $82.00B total Bitcoin volume.
Hourly Moving Average
8 SMA $3.52 +4.09%
13 SMA $3.61 +1.50%
21 SMA $3.73 -1.88%
55 SMA $3.91 -6.32%
144 SMA $4.22 -13.17%
Price Performance
+1.31% 1 Hour Change
$3.66 from $3.61
-19.13% 7 Day Change
-$0.7002 from $4.36
-30.49% 14 Day Change
-$1.12 from $4.78
-19.40% 30 Day Change
-$0.7102 from $4.37
All Time High
March 14, 2024
$52.62 -93.05%
-$48.96 vs. now
24H Change
-31.79M USD -7.99%
-404 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
5.00 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
23.27M INJ
traded over past 24 hours
23.27% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently trading at $3.52, reflecting a significant decline of 11.76% over the past 24 hours. The price has ranged between a high of $4 and a low of $3.38 during this period, indicating heightened volatility and selling pressure.
Trading volume stands at approximately $80.2 million, with a volume-to-market cap ratio of 22.85%, suggesting that the asset is experiencing substantial trading activity relative to its market capitalization. The daily range of 0.62% further illustrates the limited price movement, which is indicative of bearish sentiment in the short term.
Technical indicators show that all short-term moving averages (8 SMA, 13 SMA, and 21 SMA) are trading significantly below the current price, reinforcing the bearish trend. The 55 SMA and 144 SMA also reflect declining values, with respective declines of 11.92% and 17.22%, indicating persistent downward pressure on the price.
The 1-hour Relative Strength Index (RSI) is at an extreme low of 6, suggesting that INJ is severely oversold in the short term. Meanwhile, the 7-day RSI of 40 and the significant price declines over the past 7, 14, and 30 days (-22.29%, -34.47%, and -21.53% respectively) further affirm a lack of bullish momentum.
Given the current market dynamics, including the sharp price drop, bearish moving averages, and oversold RSI levels, a consolidation phase may occur before any potential recovery. However, with no immediate bullish signals and continued selling pressure evident in both technical and fundamental data, the outlook remains negative.
Rating: Sell. The combination of substantial price decline, bearish technical indicators, and oversold conditions suggests that further downside risk remains. Investors should consider exiting their positions until clearer bullish signals emerge.
Trading volume stands at approximately $80.2 million, with a volume-to-market cap ratio of 22.85%, suggesting that the asset is experiencing substantial trading activity relative to its market capitalization. The daily range of 0.62% further illustrates the limited price movement, which is indicative of bearish sentiment in the short term.
Technical indicators show that all short-term moving averages (8 SMA, 13 SMA, and 21 SMA) are trading significantly below the current price, reinforcing the bearish trend. The 55 SMA and 144 SMA also reflect declining values, with respective declines of 11.92% and 17.22%, indicating persistent downward pressure on the price.
The 1-hour Relative Strength Index (RSI) is at an extreme low of 6, suggesting that INJ is severely oversold in the short term. Meanwhile, the 7-day RSI of 40 and the significant price declines over the past 7, 14, and 30 days (-22.29%, -34.47%, and -21.53% respectively) further affirm a lack of bullish momentum.
Given the current market dynamics, including the sharp price drop, bearish moving averages, and oversold RSI levels, a consolidation phase may occur before any potential recovery. However, with no immediate bullish signals and continued selling pressure evident in both technical and fundamental data, the outlook remains negative.
Rating: Sell. The combination of substantial price decline, bearish technical indicators, and oversold conditions suggests that further downside risk remains. Investors should consider exiting their positions until clearer bullish signals emerge.
Updated 379 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
You May Also Like
In The News

RIVER sell-off deepens – Will prices dip further as liquidity drains?
There has been a sharp capital outflow from RIVER, dampening price action and putting sustained pressure on what was once a firmly bullish outlook.

ETF Red Tide: Bitcoin, Ether Sink Deeper as XRP Defies the Trend
Crypto exchange-traded funds (ETFs) extended their losing streak as bitcoin, ether, and solana bled heavily once again, while XRP stood out as the lone bright spot.

Binance shifts $1B SAFU into Bitcoin: Why it matters for BTC
Binance’s move sparks mixed reactions as BTC dominance nears 60%, testing hedge status against metals.

VC Roundup: Crypto funding rebounds as institutions test onchain finance
From venture rounds to onchain credit, capital is moving cautiously back into crypto as institutions focus on infrastructure and real-world use cases.